GRAHAM RICHARD A (SVP, Development) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/22/2023ACC: 0001415889-23-015448
Officer· SVP, Development
Since Aug 2020
-12.63K
Net shares
Net seller
$131.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
12.63K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−12.63K
Price / share
$10.37
Trade value
$130.97K
% of position
3.6%
11/20/2023
346.84K→334.21K
Total
Net shares
−12.63K
Net value
-$130.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/20/2023 | F · Tax Withholding | −12.63K | $10.37 | $130.97K | 3.6% | 346.84K | 334.21K |
| Total | −12.63K | -$130.97K | ||||||
Derivative Transactions0
No derivative transactions reported